• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bristol-Myers Squibb

Bristol-Myers Squibb

VY® T. Rowe Price Equity Income S IRPSX 3 Star

Last Price$14.38Day Change (%)0.35%
Open Price$14.38Day Change ($)0.05
Day Range14.38–14.3852-Week Range12.86–14.56

As of Tue 05/23/2017 | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Hepatitis Therapeutics Market to Reach $25.8 Billion by 2025 - Key Players are Gilead, Merck, Johnson & Johnson, Bristol-Myers Squibb Company & AbbVie - Research and Markets

    Hepatitis Therapeutics Market to Reach $25.8 Billion by 2025 - Key Players are Gilead, Merck, Johnson & Johnson, Bristol-Myers Squibb Company & AbbVie - Research and Markets

  2. Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer

    Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer

  3. Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer

    Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in Combination with Opdivo and Standard Chemotherapy in First Line Non-Small Cell Lung Cancer

  4. European Commission Approves Bristol-Myers Squibb ’s Opdivo (nivolumab) for Squamous Cell Cancer of the Head and Neck in Adults Progressing On or After Platinum-based Therapy

    European Commission Approves Bristol-Myers Squibb ’s Opdivo (nivolumab) for Squamous Cell Cancer of the Head and Neck in Adults Progressing On or After Platinum-based Therapy

  5. Research and Markets Has Announced the Launch of their Bristol-Myers Squibb Market Research Portal

    Research and Markets Has Announced the Launch of their Bristol-Myers Squibb Market Research Portal

  6. Bristol-Myers Squibb to Take Part in UBS Global Healthcare Conference

    Bristol-Myers Squibb to Take Part in UBS Global Healthcare Conference

  7. Hepatitis C Therapy Approved in China -- WSJ

    Hepatitis C Therapy Approved in China -- WSJ

  8. MARKET SNAPSHOT: U.S. Stocks Set To Tip Higher With Earnings Deluge In Focus

    MARKET SNAPSHOT: U.S. Stocks Set To Tip Higher With Earnings Deluge In Focus

  9. UPDATE: U.S. stocks edge higher as Wall Street absorbs earnings deluge

    UPDATE: U.S. stocks edge higher as Wall Street absorbs earnings deluge

  10. MARKET SNAPSHOT: U.S. Stocks Edge Higher As Wall Street Absorbs Earnings Deluge

    MARKET SNAPSHOT: U.S. Stocks Edge Higher As Wall Street Absorbs Earnings Deluge

12345

©2017 Morningstar Advisor. All right reserved.